Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thymus Neoplasms | 5 | 2024 | 274 | 0.930 |
Why?
|
Neoplasms, Glandular and Epithelial | 6 | 2024 | 487 | 0.730 |
Why?
|
Breast Neoplasms | 15 | 2024 | 21017 | 0.440 |
Why?
|
Thymoma | 2 | 2024 | 187 | 0.260 |
Why?
|
Paclitaxel | 5 | 2024 | 1728 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2024 | 11709 | 0.240 |
Why?
|
Herpesvirus 8, Human | 1 | 2024 | 255 | 0.210 |
Why?
|
Receptors, Glucocorticoid | 1 | 2023 | 295 | 0.190 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 374 | 0.190 |
Why?
|
Carboplatin | 1 | 2024 | 788 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2020 | 345 | 0.180 |
Why?
|
Autoimmune Diseases | 2 | 2023 | 2244 | 0.180 |
Why?
|
Lymphopenia | 1 | 2022 | 280 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2020 | 555 | 0.170 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 131 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 126 | 0.160 |
Why?
|
Cystectomy | 2 | 2021 | 697 | 0.150 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2021 | 2276 | 0.140 |
Why?
|
MicroRNAs | 2 | 2023 | 3783 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2023 | 2858 | 0.140 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2020 | 237 | 0.140 |
Why?
|
Sarcopenia | 1 | 2022 | 372 | 0.140 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2024 | 936 | 0.140 |
Why?
|
Basophils | 1 | 2019 | 404 | 0.140 |
Why?
|
BCG Vaccine | 1 | 2019 | 371 | 0.130 |
Why?
|
Fatigue | 2 | 2024 | 1542 | 0.130 |
Why?
|
Italy | 3 | 2024 | 839 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2022 | 949 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 748 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2443 | 0.120 |
Why?
|
Leptin | 1 | 2022 | 1591 | 0.120 |
Why?
|
Quality of Life | 4 | 2024 | 13286 | 0.120 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 938 | 0.120 |
Why?
|
Triage | 1 | 2020 | 986 | 0.110 |
Why?
|
Neoplasms | 4 | 2024 | 22030 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3076 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3196 | 0.100 |
Why?
|
Clinical Trials, Phase III as Topic | 3 | 2022 | 851 | 0.100 |
Why?
|
Medical Oncology | 2 | 2021 | 2312 | 0.100 |
Why?
|
Receptor, erbB-2 | 4 | 2023 | 2553 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2053 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10146 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1530 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9273 | 0.090 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13591 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 1870 | 0.080 |
Why?
|
Humans | 35 | 2024 | 758381 | 0.080 |
Why?
|
Female | 23 | 2024 | 390316 | 0.080 |
Why?
|
Waist Circumference | 2 | 2023 | 922 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4313 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2020 | 627 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3765 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4876 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6313 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5349 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11152 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 4 | 2021 | 5629 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10719 | 0.060 |
Why?
|
Prospective Studies | 6 | 2024 | 54136 | 0.050 |
Why?
|
Anorexia | 1 | 2024 | 154 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3527 | 0.050 |
Why?
|
Virus Activation | 1 | 2024 | 319 | 0.050 |
Why?
|
Waist-Hip Ratio | 1 | 2023 | 516 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5691 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5797 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 219560 | 0.050 |
Why?
|
Nausea | 1 | 2024 | 677 | 0.050 |
Why?
|
Vomiting | 1 | 2024 | 651 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 374 | 0.040 |
Why?
|
Adipokines | 1 | 2022 | 311 | 0.040 |
Why?
|
Leucovorin | 1 | 2022 | 641 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2021 | 4901 | 0.040 |
Why?
|
Ketones | 1 | 2021 | 183 | 0.040 |
Why?
|
Aged | 8 | 2024 | 168217 | 0.040 |
Why?
|
Furans | 1 | 2021 | 199 | 0.040 |
Why?
|
Male | 12 | 2024 | 358742 | 0.040 |
Why?
|
Phenylthiohydantoin | 1 | 2021 | 204 | 0.040 |
Why?
|
Piperazines | 2 | 2020 | 2511 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 575 | 0.040 |
Why?
|
Administration, Intravesical | 1 | 2019 | 92 | 0.040 |
Why?
|
Hand Strength | 1 | 2022 | 452 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13245 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 614 | 0.040 |
Why?
|
Geography | 1 | 2020 | 659 | 0.040 |
Why?
|
Pyridines | 2 | 2020 | 2860 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2022 | 870 | 0.040 |
Why?
|
Androstadienes | 1 | 2019 | 348 | 0.040 |
Why?
|
Taxoids | 1 | 2021 | 668 | 0.040 |
Why?
|
Adult | 8 | 2024 | 219916 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 998 | 0.040 |
Why?
|
Fluorouracil | 1 | 2022 | 1631 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 4641 | 0.030 |
Why?
|
Myocarditis | 1 | 2024 | 766 | 0.030 |
Why?
|
Obesity | 3 | 2023 | 12870 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1694 | 0.030 |
Why?
|
Purines | 1 | 2019 | 605 | 0.030 |
Why?
|
Nitriles | 1 | 2021 | 957 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11336 | 0.030 |
Why?
|
Aminopyridines | 1 | 2019 | 564 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5248 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1368 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1113 | 0.030 |
Why?
|
Cisplatin | 1 | 2021 | 1645 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1593 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1078 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 787 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1130 | 0.030 |
Why?
|
Vaccines | 1 | 2023 | 832 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2322 | 0.030 |
Why?
|
Prevalence | 2 | 2022 | 15646 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2019 | 855 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1477 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2023 | 2144 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 1038 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4567 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 982 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1372 | 0.030 |
Why?
|
Cell Cycle | 1 | 2021 | 2930 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2024 | 80170 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4106 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2901 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58681 | 0.020 |
Why?
|
RNA, Viral | 1 | 2020 | 2836 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2211 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1668 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2021 | 5864 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8611 | 0.020 |
Why?
|
Postmenopause | 1 | 2019 | 2509 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12721 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4353 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6821 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5199 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3142 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8426 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3615 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39060 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11070 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15785 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 64379 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 12876 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9160 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10495 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14641 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7985 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 73806 | 0.020 |
Why?
|
Genomics | 1 | 2020 | 5789 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10417 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18357 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 29558 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7377 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13468 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 13959 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25953 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21273 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23341 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23883 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39873 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29915 | 0.010 |
Why?
|
Concepts
(159)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_